Literature DB >> 22445704

Negative symptoms in individuals at clinical high risk of psychosis.

Danijela Piskulic1, Jean Addington, Kristin S Cadenhead, Tyrone D Cannon, Barbara A Cornblatt, Robert Heinssen, Diana O Perkins, Larry J Seidman, Ming T Tsuang, Elaine F Walker, Scott W Woods, Thomas H McGlashan.   

Abstract

Negative symptoms are present in the psychosis prodrome. However, the extent to which these symptoms are present prior to the onset of the first episode of psychosis remains under-researched. The goal of this study is to examine negative symptoms in a sample of individuals at clinical high risk (CHR) for psychosis and to determine if they are predictive of conversion to psychosis. Participants (n=138) were all participants in the North American Prodrome Longitudinal Study (NAPLS 1) project. Negative symptoms were assessed longitudinally using the Scale of Prodromal Symptoms. The mean total negative symptom score at baseline was 11.0, with 82.0% of the sample scoring at moderate severity or above on at least one negative symptom. Over the course of 12 months, the symptoms remained in the above moderate severity range for 54.0% of participants. Associations between individual symptoms were moderate, and a factor analysis confirmed that all negative symptoms loaded heavily on one factor. Negative symptoms were more severe and persistent overtime in those who converted to psychosis, significantly predicting the likelihood of conversion. Thus, early and persistent negative symptoms may represent a vulnerability for risk of developing psychosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22445704      PMCID: PMC4119605          DOI: 10.1016/j.psychres.2012.02.018

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  22 in total

1.  Factorial structure of the Scale of Prodromal Symptoms.

Authors:  K A Hawkins; T H McGlashan; D Quinlan; T J Miller; D O Perkins; R B Zipursky; J Addington; S W Woods
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

2.  Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'.

Authors:  Oliver Mason; Mike Startup; Sean Halpin; Ulrich Schall; Agatha Conrad; Vaughan Carr
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

3.  The initial prodrome in psychosis: descriptive and qualitative aspects.

Authors:  A R Yung; P D McGorry
Journal:  Aust N Z J Psychiatry       Date:  1996-10       Impact factor: 5.744

Review 4.  The prodromal phase of first-episode psychosis: past and current conceptualizations.

Authors:  A R Yung; P D McGorry
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

5.  Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders.

Authors:  T R Kwapil
Journal:  J Abnorm Psychol       Date:  1998-11

6.  Social outcome in early psychosis.

Authors:  J Addington; J Young; D Addington
Journal:  Psychol Med       Date:  2003-08       Impact factor: 7.723

7.  A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.

Authors:  K T Mueser; S L Sayers; N R Schooler; R M Mance; G L Haas
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

8.  Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia.

Authors:  Todd Lencz; Christopher W Smith; Andrea Auther; Christoph U Correll; Barbara Cornblatt
Journal:  Schizophr Res       Date:  2004-05-01       Impact factor: 4.939

9.  Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Colleen A McFarlane; Mats Hallgren; Patrick D McGorry
Journal:  Schizophr Res       Date:  2003-03-01       Impact factor: 4.939

10.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Patrick D McGorry
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  102 in total

1.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

Review 2.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

3.  Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project.

Authors:  Michele Poletti; Lorenzo Pelizza; Silvia Azzali; Federica Paterlini; Sara Garlassi; Ilaria Scazza; Luigi Rocco Chiri; Eva Gebhardt; Simona Pupo; Raballo Andrea
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-12-01       Impact factor: 4.785

4.  Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.

Authors:  Ehud Mekori-Domachevsky; Yael Guri; James Yi; Omri Weisman; Monica E Calkins; Sunny X Tang; Raz Gross; Donna M McDonald-McGinn; Beverly S Emanuel; Elaine H Zackai; Gil Zalsman; Abraham Weizman; Ruben C Gur; Raquel E Gur; Doron Gothelf
Journal:  Schizophr Res       Date:  2016-12-29       Impact factor: 4.939

5.  Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.

Authors:  Jean Addington; Hely Shah; Lu Liu; Donald Addington
Journal:  Schizophr Res       Date:  2014-01-16       Impact factor: 4.939

6.  North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Authors:  Jean Addington; Lu Liu; Lisa Buchy; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Thomas H McGlashan
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

7.  Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.

Authors:  Daniel Fulford; Tara A Niendam; Erin G Floyd; Cameron S Carter; Daniel H Mathalon; Sophia Vinogradov; Barbara K Stuart; Rachel L Loewy
Journal:  Schizophr Res       Date:  2013-04-12       Impact factor: 4.939

8.  Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis.

Authors:  Jimmy Choi; Cheryl M Corcoran; Joanna M Fiszdon; Michael Stevens; Daniel C Javitt; Melissa Deasy; Lawrence C Haber; Michael J Dewberry; Godfrey D Pearlson
Journal:  Psychiatr Rehabil J       Date:  2016-08-25

9.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

10.  'At-risk' for psychosis research: where are we heading?

Authors:  A Lin; B Nelson; A R Yung
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-30       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.